(571) 447-5500

EAS Blog

EAS Independent Consultants and staff provide in-depth regulatory expertise and authoritative reporting on a variety of compliance requirements for industries that EAS serves. Our experts break down complicated topics into easily understandable summaries and analysis. Subscribe to our newsletter and receive these monthly updates directly in your in-box.

Why FDA Views Registration as a FSMA Priority

The Food Safety Modernization Act’s provisions on food facility registration are especially significant from FDA’s perspective because they will enable the agency to know much more about the businesses whose products are covered by the landmark law. On July 14, 2016, the agency issued a final...

read more

FDA’s Design Control Requirements for Medical Devices

By Kaiser Aziz, PhD., EAS Senior Consultant FDA reviewers and field investigators evaluate design control requirements and processes for medical devices and make recommendations based on whether the manufacturer has the required checks and balances in place. Design controls are a mechanism for...

read more
FDA’s Design Control Requirements for Medical Devices

FDA’s Design Control Requirements for Medical Devices

FDA reviews, evaluates, verifies and validates the implementation of the design control requirements described in the device premarket applications (510k/ PMA). Design control requirements play a key role from the device design prototype, the manufacturing process to …

read more

How to Successfully Respond to FDA 483s and Warning Letters

EAS Senior Advisor for Quality and Compliance, Mr. Robert Fish, will present a webinar on How to Respond to FDA 483s and Warning Letters. He will discuss the correct and incorrect way to prepare these responses with emphasis on the FDA’s expectations. He will also explain why companies may receive an FDA 483 and how to respond in a way to prevent the issuance of a Warning Letter.”

read more

FDA Unveils FSMA Final Rule on Intentional Adulteration

FDA has now released its seventh FSMA rule – on intentional adulteration. Published May 27 in the Federal Register, the rule requires registered food facilities to develop a written food defense plan to address intentional adulteration. In an approach similar to developing a hazard analysis and...

read more

FSMA and Dietary Supplements

By Charles Breen, EAS Senior Advisor for FSMA Consulting Services FSMA’s preventive controls rule, 21 CFR 117.5(e), exempts finished dietary supplements (DS) from the requirements for preventive controls and a supply-chain program if they are in compliance with 21 CFR 111, and with adverse event...

read more

What Makes a Good Sampling Plan?

By EAS Senior Consultant William R. Fairweather, PhD. You have a question, so you design a study to explore it. You determine that A is better than B and that the average difference is 3 units. It should be obvious that this is not sufficient information, but why not? After all, it is exactly what...

read more

Implementing FSMA for Imports is FDA’s Biggest Challenge

FDA hosted an excellent day-long public meeting on March 21, 2016 to review the import-related elements of the new FSMA regulations. In opening remarks, FDA Deputy Commissioner for Foods and Veterinary Medicine Michael Taylor noted that implementing import provisions is the agency’s biggest FSMA...

read more

The Purpose of a DEA Regulatory Investigation

By EAS Senior Consultant Karen Famiglietti Everyone has read recent newspaper and internet stories about the rise in heroin abuse and its relationship with pharmaceutical opiates that were originally prescribed for legitimate medical reasons. Unfortunately, this problem has been around since the...

read more

FSMA and Third-Party Auditing

A key piece of the regulatory jigsaw puzzle as FDA moves ahead with implementing the Food Safety Modernization Act (FSMA) is the voluntary, user-fee based program for the accreditation of third-party certification bodies to conduct food safety audits of foreign food facilities and issue food and...

read more

What Are Medical Foods (and What They are Not)

By Jeanne Hoskin, Ph.D., EAS Senior Consultant Prior to 1972 medical foods were regulated as prescription drugs under section 201(g)(1)(B) of the FD&C Act, requiring manufacturers to conduct drug trials and submit Investigational New Drug license applications and New Drug Applications. It was...

read more

Produce Final Rule Goes into Effect

The Food Safety Modernization Act (FSMA) extended FDA’s authority to include produce all the way to the farm level, which put the agency in unfamiliar regulatory territory. To avoid burdening covered facilities with unreasonable compliance demands, the agency proceeded with due caution in...

read more

FSMA Implementation Enters a New Phase

The Food and Drug Administration hosted a public meeting in Chicago on October 20, 2015 to discuss the recently released final rules on preventive controls for human and animal food, along with plans for the next phase of FSMA implementation. This was a substantive meeting and I encourage you to...

read more

New Drug Development in the 21st Century

By Nancy Chew Most people who work in the pharmaceutical industry know that drug development comprises of pharmaceutical development, animal pharmacology and toxicology studies, and clinical research; many also know that there are quality standards applied to manufacturing and controls that...

read more

Managing FDA Inspections

With FDA inspections becoming more frequent, particularly in the dietary supplement world, it is imperative that companies familiarize themselves with how to host and manage such an inspection. We say “manage an FDA inspection” because the more knowledge a company has the better able it will be to make the inspection process move smoothly in the direction that you help set. To provide you with that knowledge, this webinar will cover:

read more

Preparing for FDA Foreign Drug Inspection

By EAS Senior Consultant Robert C. Fish An FDA drug inspection can be a very stressful experience. If it is a pre-approval inspection there is a lot at stake concerning the outcome. If the company does not pass, the application (NDA/ANDA) may not be approved or the approval may be significantly...

read more

When Should a Drug Compounder Register as an Outsourcing Facility?

By EAS Senior Consultants Len Valenti and Douglass Oeller When is it appropriate for a compounding pharmacy to register as an outsourcing facility under 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act)? The Drug Quality and Security Act (DQSA), signed into law on November 27, 2013,...

read more

A FSMA Milestone 

As I prepare this FSMA Perspective article, we are anticipating a significant milestone in the implementation of FSMA's preventive control philosophy – release of a final rule on current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Human Food and a...

read more

FDA’s New Medical Device Regulations 

By EAS Senior Consultant Kevin Walls The Food and Drug Administration has recently implemented two new rules that affect all medical device manufacturers, initial distributors and repackager/relabelers. The first new rule that went into effect on September 24, 2014, but up until now affected fewer...

read more

FDA Invites Comment on Draft Mandatory Recall Guidance

The Food and Drug Administration issued draft guidance on mandatory recalls in a May 7, 2015 Federal Register notice and is inviting public comment by July 6. The draft document presents the agency’s current thinking on how the food industry can implement the mandatory food recall provisions the...

read more

When the FDA Inspector Wants to Take Photographs

By EAS Senior Consultant Joseph Famiglietti Managing an FDA inspection is in itself a difficult task, but what should you do when an FDA investigator wants to take photographs at your facility? Whether it is pest sightings, equipment issues, or poor employee practices, the investigator has been...

read more

FDA Briefs Stakeholders at FSMA Public Meeting

  FDA officials discussed their “work in progress” toward implementing the Food Safety Modernization Act at a public meeting hosted by the agency in Washington, D.C. April 23-24, 2015. The agency is currently considering some new inspection ideas, they explained. For example, they may...

read more